Drug resistance

Global action plan on antimicrobial resistance

At the Sixty-eight World Health Assembly in May 2015, the World Health Assembly endorsed a global action plan to tackle antimicrobial resistance - including antibiotic resistance, the most urgent drug resistance trend.

Antimicrobial resistance is occurring everywhere in the world, compromising our ability to treat infectious diseases, as well as undermining many other advances in health and medicine. The goal of the draft global action plan is to ensure, for as long as possible, continuity of successful treatment and prevention of infectious diseases with effective and safe medicines that are quality-assured, used in a responsible way, and accessible to all who need them.

The global action plan is available at the link below.

To achieve this goal, the global action plan sets out five strategic objectives:

  • to improve awareness and understanding of antimicrobial resistance;
  • to strengthen knowledge through surveillance and research;
  • to reduce the incidence of infection;
  • to optimize the use of antimicrobial agents; and
  • develop the economic case for sustainable investment that takes account of the needs of all countries, and increase investment in new medicines, diagnostic tools, vaccines and other interventions.

Development of this plan was guided by the advice of countries and key stakeholders, based on several multistakeholder consultations at different global and regional forums.

In the course of the development of the global action plan, the WHO Secretariat considered many existing plans, initiatives and activities. Information on these plans and activities has been summarized and is made available at the link below.